1. Home
  2. FEIM vs TLSA Comparison

FEIM vs TLSA Comparison

Compare FEIM & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEIM
  • TLSA
  • Stock Information
  • Founded
  • FEIM 1961
  • TLSA 2013
  • Country
  • FEIM United States
  • TLSA United Kingdom
  • Employees
  • FEIM N/A
  • TLSA N/A
  • Industry
  • FEIM Electrical Products
  • TLSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • FEIM Industrials
  • TLSA Health Care
  • Exchange
  • FEIM Nasdaq
  • TLSA Nasdaq
  • Market Cap
  • FEIM 224.9M
  • TLSA 187.0M
  • IPO Year
  • FEIM N/A
  • TLSA 2000
  • Fundamental
  • Price
  • FEIM $22.51
  • TLSA $1.50
  • Analyst Decision
  • FEIM
  • TLSA
  • Analyst Count
  • FEIM 0
  • TLSA 0
  • Target Price
  • FEIM N/A
  • TLSA N/A
  • AVG Volume (30 Days)
  • FEIM 303.2K
  • TLSA 260.9K
  • Earning Date
  • FEIM 07-21-2025
  • TLSA 07-15-2025
  • Dividend Yield
  • FEIM 4.67%
  • TLSA N/A
  • EPS Growth
  • FEIM 604.98
  • TLSA N/A
  • EPS
  • FEIM 2.41
  • TLSA N/A
  • Revenue
  • FEIM $65,400,999.00
  • TLSA N/A
  • Revenue This Year
  • FEIM N/A
  • TLSA N/A
  • Revenue Next Year
  • FEIM N/A
  • TLSA N/A
  • P/E Ratio
  • FEIM $8.88
  • TLSA N/A
  • Revenue Growth
  • FEIM 24.10
  • TLSA N/A
  • 52 Week Low
  • FEIM $8.81
  • TLSA $0.63
  • 52 Week High
  • FEIM $24.77
  • TLSA $1.91
  • Technical
  • Relative Strength Index (RSI)
  • FEIM 54.24
  • TLSA 48.99
  • Support Level
  • FEIM $20.34
  • TLSA $1.53
  • Resistance Level
  • FEIM $24.50
  • TLSA $1.81
  • Average True Range (ATR)
  • FEIM 1.56
  • TLSA 0.11
  • MACD
  • FEIM -0.10
  • TLSA -0.01
  • Stochastic Oscillator
  • FEIM 49.78
  • TLSA 11.76

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: